Get started
Markets US Stocks Health Technology Pharmaceuticals: Major

Kinnate Biopharma Inc KNTE

KNTE NASDAQ
KNTE
Kinnate Biopharma Inc NASDAQ
See more on advanced chartSee more on advanced chart
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals Analysis

KNTE Chart

Ideas

Kinnate Biopharma KNTE Holding Support for Long Setup
KNTE
, 1DLong
KNTE: Kinnate Biopharma KNTE Holding Support for Long Setup

Kinnate Biopharma is holding support for a possible move up here. Stop loss is important. Not financial advice.

KNTE: IPO Watch
KNTE
, 60Long
KNTE: KNTE: IPO Watch

If the breakout holds we will see higher prices. IPO's are generally high risk .

$KNTE is giving a GREAT IPO LONG opportunity today
KNTE
, 15Long
KNTE: $KNTE is giving a GREAT IPO LONG opportunity today

IPO intraday trading strategy idea Kinnate Biopharma is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The share price is rising and gonna continue this trend today. The demand for shares of the company still looks higher than the supply. These and...

Technicals

Analyst rating

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA.

Breaking news

More news